Citation: A. Cada et al., REGIONAL BRAIN EFFECTS OF SODIUM-AZIDE TREATMENT ON CYTOCHROME-OXIDASE ACTIVITY - A QUANTITATIVE HISTOCHEMICAL-STUDY, Metabolic brain disease, 10(4), 1995, pp. 303-320
Citation: J. Sypecka et al., OLIGODENDROCYTE DEVELOPMENT IN PLP PT MUTANT RABBITS - GLYCOLIPID ANTIGENS AND PLP GENE-EXPRESSION, Metabolic brain disease, 10(4), 1995, pp. 321-333
Authors:
AMODIO P
MARCHETTI P
DELPICCOLO F
SARTORI G
PRIOR M
MERKEL C
GATTA A
Citation: P. Amodio et al., VISUAL-ATTENTION ORIENTING IN LIVER-CIRRHOSIS WITHOUT OVERT HEPATIC-ENCEPHALOPATHY, Metabolic brain disease, 10(4), 1995, pp. 335-345
Citation: Ts. Whittingham et al., CREATINE AND NUCLEOSIDE TRIPHOSPHATES IN RAT CEREBRAL GRAY AND WHITE-MATTER, Metabolic brain disease, 10(4), 1995, pp. 347-352
Authors:
LAYRARGUES GP
SHAPCOTT D
SPAHR L
BUTTERWORTH RF
Citation: Gp. Layrargues et al., ACCUMULATION OF MANGANESE AND COPPER IN PALLIDUM OF CIRRHOTIC-PATIENTS - ROLE IN THE PATHOGENESIS OF HEPATIC-ENCEPHALOPATHY, Metabolic brain disease, 10(4), 1995, pp. 353-356
Citation: Nr. Sims, CALCIUM, ENERGY-METABOLISM AND THE DEVELOPMENT OF SELECTIVE NEURONAL LOSS FOLLOWING SHORT-TERM CEREBRAL-ISCHEMIA, Metabolic brain disease, 10(3), 1995, pp. 191-217
Authors:
WEISSENBORN K
EHRENHEIM C
HORI A
KUBICKA S
MANNS MP
Citation: K. Weissenborn et al., PALLIDAL LESIONS IN PATIENTS WITH LIVER-CIRRHOSIS - CLINICAL AND MRI EVALUATION, Metabolic brain disease, 10(3), 1995, pp. 219-231
Authors:
AGUGLIA U
GAMBARDELLA A
OLIVERI RL
DESARRO G
ZAPPIA M
QUATTRONE A
Citation: U. Aguglia et al., DE-NOVO EPILEPTIC CONFUSIONAL STATUS IN A PATIENT WITH COBALAMIN DEFICIENCY, Metabolic brain disease, 10(3), 1995, pp. 233-238
Citation: A. Watanabe et al., EVALUATION OF NEUROPSYCHOLOGICAL FUNCTION IN PATIENTS WITH LIVER-CIRRHOSIS WITH SPECIAL REFERENCE TO THEIR DRIVING ABILITY, Metabolic brain disease, 10(3), 1995, pp. 239-248
Citation: L. Ratnakumari et al., LOSS OF [H-3] MK801 BINDING-SITES IN BRAIN IN CONGENITAL ORNITHINE TRANSCARBAMYLASE DEFICIENCY, Metabolic brain disease, 10(3), 1995, pp. 249-255
Citation: Je. Maddison et al., L-GLUTAMATE AND GAMMA-AMINOBUTYRIC-ACID UPTAKE IN SYNAPTOSOMES FROM THE CEREBRAL-CORTEX OF DOGS WITH CONGENITAL CHRONIC HEPATIC-ENCEPHALOPATHY, Metabolic brain disease, 10(2), 1995, pp. 135-141
Citation: N. Harata et Y. Iwasaki, EVIDENCE FOR EARLY BLOOD-BRAIN-BARRIER BREAKDOWN IN EXPERIMENTAL THIAMINE-DEFICIENCY IN THE MOUSE, Metabolic brain disease, 10(2), 1995, pp. 159-174
Authors:
TAYLORROBINSON SD
OATRIDGE A
HAJNAL JV
BURROUGHS AK
MCINTYRE N
DESOUZA NM
Citation: Sd. Taylorrobinson et al., MR-IMAGING OF THE BASAL GANGLIA IN CHRONIC LIVER-DISEASE - CORRELATION OF T-1-WEIGHTED AND MAGNETIZATION-TRANSFER CONTRAST MEASUREMENTS WITH LIVER DYSFUNCTION AND NEUROPSYCHIATRIC STATUS, Metabolic brain disease, 10(2), 1995, pp. 175-188
Citation: Jj. Kril, THE CONTRIBUTION OF ALCOHOL, THIAMINE-DEFICIENCY AND CIRRHOSIS OF THELIVER TO CEREBRAL CORTICAL DAMAGE IN ALCOHOLICS, Metabolic brain disease, 10(1), 1995, pp. 9-16
Authors:
HARPER C
FORNES P
DUYCKAERTS C
LECOMTE D
HAUW JJ
Citation: C. Harper et al., AN INTERNATIONAL PERSPECTIVE ON THE PREVALENCE OF THE WERNICKE-KORSAKOFF-SYNDROME, Metabolic brain disease, 10(1), 1995, pp. 17-24
Citation: Pj. Langlais, PATHOGENESIS OF DIENCEPHALIC LESIONS IN AN EXPERIMENTAL-MODEL OF WERNICKES ENCEPHALOPATHY, Metabolic brain disease, 10(1), 1995, pp. 31-44
Citation: Pr. Martin et al., MOLECULAR-GENETICS OF TRANSKETOLASE IN THE PATHOGENESIS OF THE WERNICKE-KORSAKOFF-SYNDROME, Metabolic brain disease, 10(1), 1995, pp. 45-55
Citation: B. Wood et J. Currie, PRESENTATION OF ACUTE WERNICKES ENCEPHALOPATHY AND TREATMENT WITH THIAMINE, Metabolic brain disease, 10(1), 1995, pp. 57-72